Simplex Trading
GBT

Simplex Trading’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Simplex Trading’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-91,600
Closed -$77K – 11119
2022
Q3 		$77K Buy
91,600
+71,800
+363% +$3.96M ﹤0.01% 5881
2022
Q2 		$632K Buy
19,800
+13,900
+236% +$407K ﹤0.01% 3168
2022
Q1 		$204K Sell
5,900
-15,600
-73% -$466K ﹤0.01% 5126
2021
Q4 		$629K Sell
21,500
-5,600
-21% -$173K ﹤0.01% 3494
2021
Q3 		$1.01M Buy
27,100
+1,500
+6% +$44.1K ﹤0.01% 3055
2021
Q2 		$896K Buy
25,600
+25,280
+7,900% +$987K ﹤0.01% 3279
2021
Q1 		$1.3M Sell
320
-438
-58% -$20.1K ﹤0.01% 2110
2020
Q4 		$3.28M Buy
758
+629
+488% +$31K ﹤0.01% 1312
2020
Q3 		$711K Sell
129
-117
-48% -$7.44K ﹤0.01% 2615
2020
Q2 		$1.55M Buy
246
+132
+116% +$9.05K ﹤0.01% 1739
2020
Q1 		$582K Sell
114
-554
-83% -$37.1K ﹤0.01% 2436
2019
Q4 		$5.31M Buy
668
+128
+24% +$7.58K 0.01% 767
2019
Q3 		$2.62M Buy
540
+160
+42% +$8.34K 0.01% 1124
2019
Q2 		$2M Buy
380
+90
+31% +$5.17K 0.01% 1315
2019
Q1 		$1.53M Buy
290
+24
+9% +$1.18K ﹤0.01% 1609
2018
Q4 		$1.09M Sell
266
-155
-37% -$5.81K ﹤0.01% 1566
2018
Q3 		$1.6M Sell
421
-938
-69% -$41.5K 0.01% 1440
2018
Q2 		$6.14M Buy
1,359
+1,027
+309% +$46.8K 0.02% 488
2018
Q1 		$279K Sell
332
-324
-49% -$18.1K 0.01% 1032
2017
Q4 		$418K Buy
656
+389
+146% +$14.5K 0.02% 816
2017
Q3 		$91K Buy
267
+26
+11% +$731 ﹤0.01% 1799
2017
Q2 		$47K Sell
241
-664
-73% -$19.8K ﹤0.01% 2459
2017
Q1 		$401K Buy
905
+742
+455% +$18.7K 0.02% 799
2016
Q4 		$2K Sell
163
-58
-26% -$1.02K ﹤0.01% 5177
2016
Q3 		$66K Buy
221
+99
+81% +$1.89K ﹤0.01% 1876
2016
Q2 		$6K Buy
+122
New +$2.46K ﹤0.01% 4144

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Simplex Trading's GBT Position: Q4 2022 in Review

Simplex Trading sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 3,250 shares — an estimated $221K sold.

Simplex Trading first reported a position in GBT in Q1 2016 and held it in 16 quarters. The position peaked at $2.52M in Q4 2020. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Simplex Trading reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Simplex Trading sold 3,250 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $221K.
  • Simplex Trading first reported a position in Global Blood Therapeutics, Inc. in Q1 2016 and held it in 16 quarters.
  • Simplex Trading's Global Blood Therapeutics, Inc. position peaked at $2.52M in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.